Deployment of polysaccharide markers for treating a site within a patent
09820824 · 2017-11-21
Assignee
Inventors
Cpc classification
A61B2017/00004
HUMAN NECESSITIES
A61B2090/3966
HUMAN NECESSITIES
A61B90/39
HUMAN NECESSITIES
International classification
Abstract
A method for treating a site within a patient from which tissue has been removed includes providing at least one press-formed marker body formed of polysaccharide and a suitable binder; and placing the at least one of the press-formed marker body within the site where tissue has been removed so as to provide hemostasis therein.
Claims
1. A system for delivery of at least one tissue marker to a site within a patient, comprising: a marker delivery device having a delivery tube with an inner lumen and a discharge port, and a plunger slidably disposed within the inner lumen of the delivery tube, the plunger having a proximal end and a distal end, the proximal end having a head configured to allow an operator to move the plunger within the inner lumen; and a press-formed marker body disposed in the inner lumen distal to the distal end of the plunger, wherein the press-formed marker body is formed of a mixture of 65% (by wt.) powder of corn starch or potato starch and 35% (by wt.) methylcellulose binder, and wherein moving the plunger in a distal direction pushes the press-formed marker body out of the discharge port and into the site within the patient.
2. The system of claim 1, further comprising a releasable plug positioned in the discharge port distal to the press-formed marker body.
3. The system of claim 1, wherein the mixture is placed in a pellet die and subjected to pressure, the press-formed marker body having a pair of opposed flat surfaces and a pair of opposed convex surfaces, the pair of opposed convex surfaces being orthogonal to the pair of opposed flat surfaces.
4. A system for delivery of tissue markers to a site within a patient, comprising: a marker delivery device having a delivery tube with an inner lumen and a discharge port, and a plunger slidably disposed within the inner lumen of the delivery tube, the plunger having a proximal end and a distal end, the proximal end having a head configured to allow an operator to move the plunger within the inner lumen; and a plurality of marker members positioned in the delivery tube distal to the plunger, each marker member of the plurality of marker members comprising a press-formed marker body formed of bioabsorbable polysaccharide and a binder, the bioabsorbable polysaccharide being in sufficient amounts to exhibit hemostatic properties, wherein at least one of the plurality of marker members is formed of a mixture of 65% (by wt.) powder of corn starch or potato starch and 35% (by wt.) methylcellulose binder.
5. The system of claim 4, wherein each of the plurality of marker elements is urged out the discharge port by a distal movement of the plunger.
6. The system of claim 4, wherein another at least one marker element of the plurality of marker elements is about 10 to about 90% (by wt.) bioabsorbable polysaccharide.
7. The system of claim 4, wherein another at least one marker element of the plurality of marker elements is a bioabsorbable polysaccharide selected from the group consisting of starch, glycogen, cellulose, chitin, chitosan, dextran, pectins, glucans, agar, alginate and carrageen.
8. The system of claim 4, wherein the mixture is placed in a pellet die and subjected to pressure to form a unitary marker pellet, the unitary marker pellet having a pair of opposed flat surfaces and a pair of opposed convex surfaces, the pair of opposed convex surfaces being orthogonal to the pair of opposed flat surfaces.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
DETAILED DESCRIPTION OF THE INVENTION
(6)
(7) One suitable polysaccharide material is U.S.P. Topical Starch. Alternatively, Hemaderm™, which is available from Medafor, Inc. located in Minneapolis, Minn., may also be used. This product is described at least in part in U.S. Pat. No. 6,060,461.
(8) The marker member 10 may be formed in a variety of shapes and sizes, but generally the length of the marker member is at least twice, preferably five times that of the maximum transverse dimension. The marker member 10 should have sufficient column strength to allow it to be pushed within the delivery tube without significant damage. In some instances the marker member may be partially or completely coated with a bioabsorbable polymeric material such as polylactic acid, polyglycolic acid and copolymers thereof to control the dissolution of the material of the marker member.
(9) One suitable marker delivery system 15 is depicted in
(10) Releasable plug 21, preferably formed of polyethylene glycol, may substantially fill the discharge opening 26, as shown in
(11) The delivery cannula 16 may be provided with markings 30 which serve as visual landmarks to aid an operator in accurately placing the distal portion 18 of the cannula 16 in a desired location within a patient's body for discharging the marker 10.
(12) The exterior of the delivery cannula 16 is preferably configured to fit within a guide cannula sized to accept a SenoCor®, EnCor™, Mammotome® or Tru-Cut®, biopsy device. Typically, plug 21 and marker member 10 will have diameters determined by the size of the inner lumen 17 and typically will be about 0.02 inch (0.5 mm) to about 0.5 inch (12 mm), preferably about 0.04 inch (1 mm) to about 0.3 inch (8 mm) Plug 21 may have slightly larger transverse dimensions to provide a tight fit.
(13) When the marker member 10 contacts body fluid within a body cavity such as a lumpectomy or biopsy site, the binding agent is dissolved and the polysaccharide draws moisture away from the blood and other fluids at the site and the clotting cascade begins to form thrombus at the site resulting in hemostasis.
(14) While one or more particular forms of the invention have been illustrated and described herein in the context of a breast biopsy site, it will be apparent that the device and methods having features of the invention may find use in a variety of locations and in a variety of applications, in addition to the human breast, where tissue has been removed. Moreover, various modifications can be made without departing from the spirit and scope of the invention. For example, while the polysaccharide bodies are primarily described herein as press-formed bodies, the polysaccharide materials by be encapsulated in a bioabsorbable body or be in other forms. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is therefore intended that this invention to be defined by the scope of the appended claims as broadly as the prior art will permit, and in view of the specification if need be. Moreover, those skilled in the art will recognize that features shown in one embodiment may be utilized in other embodiments. Additional details of pellet or other marker members and delivery systems may be found in application Ser. No. 10/753,694, filed on Jan. 7, 2004, and Ser. No. 10/976,138, filed on Oct. 27, 2004.
(15) Terms such as “element”, “member”, “device”, “section”, “portion”, “step”, “means” and words of similar import when used in the following claims shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the following claims expressly use the term “means” followed by a particular function without specific structure or expressly use the term “step” followed by a particular function without specific action. All patents and patent applications referred to above are hereby incorporated by reference in their entirety.